Uscom Ltd

ASX:UCM ISIN:AU000000UCM2

Uscom Limited (ASX:UCM) is an Australian medical device company, listed on the Australian Stock Exchange since December 2003. Uscom has developed a device for the safe and accurate measurement of cardiac output, a non-invasive alternative to the current invasive methods. Uscom offers a completely safe, painless and quick method of accurately measuring how well the heart is pumping. With its real-time beat-to-beat information across multiple parameters of cardiac function and advanced serial measurement capabilities, clinicians can accurately quantify the impact of therapy. The device is ideally suited to the Emergency Care setting where it is critical to monitor changes in cardiac output as fluids are applied. 
 
 

View in Other Languages

News

USCOM Limited (ASX:UCM) USCOM Monitor Improves Management Of Children With Septic Shock

🕔10/8/2008 10:23:14 AM 3794

Uscom Limited (ASX:UCM)(PINK:UCMDF) today announced the release of a new study confirming that USCOM 1A improves management of septic shock in children. The research, from London's prestigious Great Ormond St Hospital for Sick Children, was published in Pediatrics, the official Journal of the American Academy of Pediatrics.

Read Full Article

USCOM LIMITED Biotech Forum<br />The Road to Commercialisation

🕔2/6/2006 3:15:00 PM 2878

USCOM LIMITED Biotech Forum
The Road to Commercialisation; Boardroomradio is pleased to announce that USCOM LIMITED (ASX: UCM) has published an audio file. The following presentation "" is now availa

Read Full Article
###

11,634 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 10) (Last 30 Days: 27) (Since Published: 5305) 

Company Data

    Headquarters
  • Suite 1, Level 7
    10 Loftus Street
    Sydney NSW 2000
    Australia
  • Telephone
  • +61-2-9247-4144 
  • Fax
  • +61-2-9247-8157 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.uscom.com.au
  • E:
  • rob@uscom.com.au

More News Results

  • 2024/10/31: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/10/29: Change of Director's Interest Notice - Phillips*
  • 2024/10/25: Notification regarding unquoted securities - UCM*
  • 2024/10/25: Results of 2024 AGM*
  • 2024/10/25: FY24 AGM Presentation and Update*
  • 2024/09/30: Notice of Annual General Meeting/Proxy Form*
  • 2024/09/24: Notice of Annual General Meeting/Proxy Form*
  • 2024/09/24: Letter to shareholders re AGM*
  • 2024/09/04: Cleansing notice*
  • 2024/09/04: Application for quotation of securities - UCM*
*refer to company website